dc.contributor.author | Farquhar, C | |
dc.contributor.author | VanCott, T | |
dc.contributor.author | Bosire, R | |
dc.contributor.author | Bermudez, C | |
dc.contributor.author | Mbori-Ngacha, DA | |
dc.contributor.author | Lohman-Payne, B | |
dc.contributor.author | Nduati, RW | |
dc.contributor.author | Otieno, P | |
dc.contributor.author | John-Stewart, G | |
dc.date.accessioned | 2013-06-10T11:42:55Z | |
dc.date.available | 2013-06-10T11:42:55Z | |
dc.date.issued | 2008-07 | |
dc.identifier.citation | Clin Exp Immunol. 2008 Jul;153(1):37-43. | en |
dc.identifier.uri | http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/18505437 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/30722 | |
dc.description.abstract | Humoral immunity, and specifically immunoglobulin A (IgA) that is directed against human immunodeficiency virus (HIV)-1, may contribute to protection against HIV-1 acquisition at mucosal surfaces. HIV-1-specific IgA has been detected in genital tract secretions of HIV-1-uninfected commercial sex workers with HIV-1 exposure, and may be produced in parotid saliva by infants exposed orally to HIV-1 during delivery and breastfeeding. To explore this hypothesis, we collected saliva from 145 infants aged < or = 6 months enrolled in a perinatal HIV-1 transmission study in Nairobi and from 55 control infants without HIV-1 exposure who were born to HIV-1-seronegative mothers. Among the 145 infants, 115 (79%) remained uninfected during the 12-month study period and 30 (21%) became HIV-1-infected during follow-up. Nine (8%) of the 115 HIV-1-exposed, uninfected infants had detectable levels of HIV-1 gp160-specific IgA compared with four (13%) of 30 infected infants and none of 55 control infants (P = 0.47 and P = 0.03 respectively). Among the nine HIV-1-exposed, uninfected infants with positive assays, median age was 1 month and none acquired HIV-1 during follow-up. We conclude that HIV-1-specific salivary IgA responses may be generated by very young infants exposed perinatally to maternal HIV-1. Mucosal responses would be an appropriate target for paediatric vaccines against breast milk HIV-1 transmission. | en |
dc.language.iso | en | en |
dc.publisher | University of Nairobi. | en |
dc.title | Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya | en |
dc.type | Article | en |
local.publisher | Department of Paediatrics and Child Health, Univeristy of Nairobi, Kenya | en |